Dr Immaculate Ann Wesley, PSYD | |
622 Del Sol Dr, Alamosa, CO 81101-8548 | |
(719) 587-6800 | |
(719) 587-6819 |
Full Name | Dr Immaculate Ann Wesley |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 622 Del Sol Dr, Alamosa, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700944196 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 1860 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Immaculate Ann Wesley, PSYD 622 Del Sol Dr, Alamosa, CO 81101-8548 Ph: (719) 587-6800 | Dr Immaculate Ann Wesley, PSYD 622 Del Sol Dr, Alamosa, CO 81101-8548 Ph: (719) 587-6800 |
News Archive
People who have the most common genetic mutation linked to obesity respond differently to pictures of appetizing foods than overweight or obese people who do not have the genetic mutation, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Depression is a common risk for people who have lost their vision from age-related macular degeneration (AMD), but a new study shows that a type of rehabilitation therapy can cut this risk in half. The study was funded by the National Eye Institute (NEI), part of the National Institutes of Health.
In a large review of breast cancer patients with mucinous carcinoma, researchers at The University of Texas M. D. Anderson Cancer Center have identified an association between this rare type of breast cancer long-associated with a favorable prognosis and multiple tumors undetected by mammography or ultrasound.
Researchers at the University of Iowa have worked out the exact function of an enzyme that is critical for normal muscle structure and is involved in several muscular dystrophies. The findings, which were published Jan. 6 in the journal Science,, could be used to develop rapid, large-scale testing of potential muscular dystrophy therapies.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and DURECT Corporation, a specialty pharmaceutical company, today announced that the companies have entered into a licensing agreement to develop and market DURECT's POSIDUR (SABER-bupivacaine) a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials.
› Verified 7 days ago
James J Grant, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 8745 County Road 9 S, Alamosa, CO 81101 Phone: 719-589-3671 Fax: 719-587-5693 |